Page 7 - Use Authorisation News Today

COVID-19: NAFDAC to give emergency approval for N400bn vaccines FG’s COVID-19 financing to hit N1tn in 2021 Health ministry to submit breakdown of vaccine budget to Nass Our Reporters The National Agency for Food and Drug Administration and Control is expected to give emergency approval for COVID-19 vaccines once they arrive in Nigeria, Saturday PUNCH has learnt. Saturday PUNCH on Friday. Adeyeye said NAFDAC would be doing something called, “Emergency Use Authorisation.” She said the age...

COVAXIN: Bharat Biotech Again Applies For Emergency Use Approval Of Its Covid-19 Vaccine Candidate Bharat Biotechs COVAXIN, India’s first indigenous vaccine against Coronavirus. (Swarajya Magazine) Hyderabad-based Bharat Biotech, which is developing the countrys indigenous coronavirus vaccine in collaboration with the Indian Council of Medical Research, on Wednesday (23 December) again applied to the Drug Controller General of India for the emergency use authorisation. "The company applied...

URL copied Bharat Biotech applies for emergency approval of coronavirus vaccine -- Covaxin. Hyderabad-based Bharat Biotech, which is developing the countrys indigenous coronavirus vaccine in collaboration with the Indian Council of Medical Research, on Wednesday again applied to the Drug Controller General of India for the emergency use authorisation. "The company applied for the emergency use authorisation in the evening," a company source told IANS. Emergency Use Authorisation is a ...

3:37 PM MYT Community leaders hand face masks to residents in Srah Chak commune in Phnom Penh’s Daun Penh district. - The Phnom Penh Post/Asian News Network PHNOM PENH, Dec 12 (The Phnom Penh Post/ANN): Covid-19 vaccines could be available for distribution in Cambodia by the middle of next year or earlier, according to the World Health Organisation (WHO). WHO representative to Cambodia Dr Li Ailan told The Post that the WHO and its partners were working hard to bring safe, eff...

The Elecsys® SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infectionRoche will be able to ramp up to a double-digit million number of tests per

Message : Required fields -- The Elecsys(R) SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection -- Roche will be able to ramp up to a double-digit million number of tests per month, by early 2021 -- The test is the latest addition to Roches comprehensive COVID-19 portfolio and can help in the management of patients for optimal care delivery Basel, 11 December 2020 - Roche (SIX: RO,...